Degertekin B - Search Results

1

Update on viral hepatitis: 2007.

Degertekin B, Lok AS. Degertekin B, et al. Curr Opin Gastroenterol. 2008 May;24(3):306-11. doi: 10.1097/MOG.0b013e3282f70285. Curr Opin Gastroenterol. 2008. PMID: 18408458 Review.

2

Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations.

Tan J, Degertekin B, Wong SN, Husain M, Oberhelman K, Lok AS. Tan J, et al. Among authors: degertekin b. J Hepatol. 2008 Mar;48(3):391-8. doi: 10.1016/j.jhep.2007.09.020. Epub 2008 Jan 3. J Hepatol. 2008. PMID: 18199519 Clinical Trial.

3

Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance.

Degertekin B, Hussain M, Tan J, Oberhelman K, Lok AS. Degertekin B, et al. J Hepatol. 2009 Jan;50(1):42-8. doi: 10.1016/j.jhep.2008.08.020. Epub 2008 Nov 5. J Hepatol. 2009. PMID: 19019484

4

What is the optimal regimen for preventing hepatitis B recurrence after liver transplantation?

Degertekin B, Lok AS. Degertekin B, et al. Nat Clin Pract Gastroenterol Hepatol. 2009 Feb;6(2):68-9. doi: 10.1038/ncpgasthep1339. Epub 2008 Dec 17. Nat Clin Pract Gastroenterol Hepatol. 2009. PMID: 19092788

5

Update on viral hepatitis: 2008.

Degertekin B, Lok AS. Degertekin B, et al. Curr Opin Gastroenterol. 2009 May;25(3):180-5. doi: 10.1097/MOG.0b013e328324f478. Curr Opin Gastroenterol. 2009. PMID: 19387254 Review.

6

Indications for therapy in hepatitis B.

Degertekin B, Lok AS. Degertekin B, et al. Hepatology. 2009 May;49(5 Suppl):S129-37. doi: 10.1002/hep.22931. Hepatology. 2009. PMID: 19399799 Free article.

7

Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation.

Degertekin B, Han SH, Keeffe EB, Schiff ER, Luketic VA, Brown RS Jr, Emre S, Soldevila-Pico C, Reddy KR, Ishitani MB, Tran TT, Pruett TL, Lok AS; NIH HBV-OLT Study Group. Degertekin B, et al. Am J Transplant. 2010 Aug;10(8):1823-33. doi: 10.1111/j.1600-6143.2010.03046.x. Epub 2010 Mar 23. Am J Transplant. 2010. PMID: 20346062 Free PMC article.

8

Characteristics of chronic hepatitis B patients who underwent liver biopsies.

Chotiyaputta W, Degertekin B, McKenna BJ, Samala N, Fontana RJ, Lok AS. Chotiyaputta W, et al. Among authors: degertekin b. J Viral Hepat. 2011 Nov;18(11):792-803. doi: 10.1111/j.1365-2893.2010.01364.x. Epub 2010 Aug 17. J Viral Hepat. 2011. PMID: 20726947 Free PMC article.

9

Should liver biopsies be performed on all hepatitis B carriers?

Degertekin B, Lok AS. Degertekin B, et al. Gastroenterology. 2008 Nov;135(5):1802; author reply 1802-3. doi: 10.1053/j.gastro.2008.09.052. Epub 2008 Oct 7. Gastroenterology. 2008. PMID: 18840439 No abstract available.

10

Monitoring antiviral resistance in patients receiving nucleos(t)ide analog therapies for hepatitis B: which method should be used?

Degertekin B, Lok AS. Degertekin B, et al. J Hepatol. 2008 Jun;48(6):892-4. doi: 10.1016/j.jhep.2008.03.010. Epub 2008 Apr 1. J Hepatol. 2008. PMID: 18433924 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page